An αtropomyosin mutation alters dimer preference in nemaline myopathy

Annals of Neurology

Volumn 57, Issue 1, 2005, Pages 42-49

  Corbett, Mark A ^a   Akkari, P Anthony ^b   Domazetovska, Ana ^c   Cooper, Sandra T ^c   North, Kathryn N ^c   Laing, Nigel G ^b   Gunning, Peter W ^c   Hardeman, Edna C ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA TROPOMYOSIN; BETA TROPOMYOSIN; DIMER; ISOPROTEIN; NEBULIN; TROPOMYOSIN; TROPONIN; UNCLASSIFIED DRUG; ARGININE; MESSENGER RNA; METHIONINE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DYNAMICS; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MOUSE; MUSCLE FIBRIL; MUSCLE WEAKNESS; NEMALINE MYOPATHY; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE; SKELETAL MUSCLE; THIN FILAMENT; TRANSGENIC MOUSE; ANIMAL; CLASSIFICATION; COMPARATIVE STUDY; DIMERIZATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MUTATION; NEWBORN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; PROTEIN SECONDARY STRUCTURE; TIME; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ARGININE; BLOTTING, NORTHERN; BLOTTING, WESTERN; DIMERIZATION; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION; HUMANS; METHIONINE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUTATION; MYOPATHIES, NEMALINE; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; RNA, MESSENGER; TIME FACTORS; TROPOMYOSIN;

EID: 11144244664     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20305     Document Type: Article

References (24)

1. Sanoudou D, Beggs AH. Clinical and genetic heterogeneity in nemaline myopathy - a disease of skeletal muscle thin filaments. Trends Mol Med 2001;7:362-368.
2. Laing NG, Wilton SD, Akkari PA, et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 1995;10:249.
3. Perry SV. Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Modi 2001;22:5-49.
4. Wolska BM, Wieczorek DM. The role of tropomyosin in the regulation of myocardial contraction and relaxation. Pflugers Arch 2003;446:1-8.
5. Clark KA, McElhinny AS, Beckerle MC, Gregorio CC. Striated muscle cytoarchitecture: an intricate web of form and function. Annu Rev Cell Dev Biol 2002;18:637-706.
6. Bronson DD, Schachat FH. Heterogeneity of contractile proteins. Differences in tropomyosin in fast, mixed, and slow skeletal muscles of the rabbit. J Biol Chem 1982;257:3937-3944.
7. Pieples K, Wieczorek DF. Tropomyosin 3 increases striated muscle isoform diversity. Biochemistry 2000;39:8291-8297.
8. Brown HR, Schachat FH. Renaturation of skeletal muscle tropomyosin: implications for in vivo assembly. Proc Nad Acad Sci U S A 1985;82:2359-2363.
9. Moraczewska J, Greenfield NJ, Liu Y, Hitchcock-DeGregori SE. Alteration of tropomyosin function and folding by a nemaline myopathy-causing mutation. Biophys J 2000;79:3217-3225.
10. Greenfield NJ, Fowler VM. Tropomyosin requires an intact N-terminal coiled coil to interact with tropomodulin. Biophys J 2002;82:2580-2591.
11. Akkari PA, Song Y, Hitchcock-DeGregori S, et al. Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy. Biochem Biophys Res Commun 2002;296:300-304.
12. Corbett MA, Robinson CS, Dunglison GF, et al. A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. Hum Mol Genet 2001;10:317-328.
13. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. Vol 2. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989.
14. Gunning P, Gordon M, Wade R, et al. Differential control of tropomyosin mRNA levels during myogenesis suggests the existence of an isoform competition-autoregulatory compensation control mechanism. Dev Biol 1990;138:443-453.
15. Lehrer SS. Intramolecular crosslinking of tropomyosin via disulfide bond formation: evidence for chain register. Proc Natl Acad Sci U S A 1975;72:3377-3381.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227: 680-685.
17. Das KM, Dasgupta A, Mandal A, Geng X. Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis. J Immunol 1993;150:2487-2493.
18. Wattanasirichaigoon D, Swoboda KJ, Takada F, et al. Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy. Neurology 2002;59:613-617.
19. Lehrer SS, Qian YD, Hvidt S. Assembly of the native heterodimer of Rana esculenta tropomyosin by chain exchange. Science 1989;246:926-928.
20. Laing NG, Majda BT, Akkari PA, et al. Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I. Am J Hum Genet 1992;50:576-583.
21. de Haan A, van der Vliet MR, Gommans IM, et al. Skeletal muscle of mice with a mutation in slow alpha-tropomyosin is weaker at lower lengths. Neuromuscul Disord 2002;12: 952-957.
22. Muthuchamy M, Grupp IL, Grupp G, et al. Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J Biol Chem 1995;270: 30593-30603.
23. Pieples K, Arteaga G, Solaro RJ, et al. Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca(2+) activation. Am J Physiol Heart Circ Physiol 2002;283:H1344-1353.
24. Palmiter KA, Kitada Y, Muthuchamy M, et al. Exchange of beta- for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding, and protein phosphorylation. J Biol Chem 1996:271:11611-11614.